NPI: 1043241110 · CHARLESTON, SC 29425 · Cardiovascular Disease Physician · NPI assigned 07/06/2006
Authorized official RAE, KARYN controls 20+ related entities in our dataset. Read more
| Authorized Official | RAE, KARYN (DIRECTOR) |
| NPI Enumeration Date | 07/06/2006 |
Other providers sharing the same authorized official: RAE, KARYN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 26,205 | $552K |
| 2019 | 24,171 | $510K |
| 2020 | 19,947 | $429K |
| 2021 | 20,294 | $448K |
| 2022 | 19,791 | $373K |
| 2023 | 15,410 | $266K |
| 2024 | 12,763 | $219K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21,590 | 20,466 | $671K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 11,597 | 11,317 | $445K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 3,858 | 1,570 | $391K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 63,019 | 56,040 | $252K |
| 99215 | Prolong outpt/office vis | 5,624 | 5,191 | $210K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 4,228 | 1,984 | $125K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2,184 | 1,736 | $108K |
| 36512 | 1,666 | 1,596 | $82K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | 4,460 | 4,386 | $79K |
| 99233 | Prolong inpt eval add15 m | 1,534 | 630 | $69K |
| 99205 | Prolong outpt/office vis | 526 | 518 | $67K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,449 | 1,390 | $33K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 438 | 422 | $33K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 15 | 13 | $32K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 374 | 368 | $31K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 958 | 578 | $23K |
| 94010 | 5,173 | 5,046 | $21K | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 1,215 | 632 | $18K |
| 90961 | 752 | 738 | $18K | |
| 94729 | 2,529 | 2,477 | $9K | |
| 93750 | 651 | 570 | $8K | |
| 99254 | 67 | 65 | $8K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 585 | 415 | $7K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 112 | 112 | $6K |
| 95782 | 68 | 65 | $6K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 17 | 12 | $5K |
| 93295 | 269 | 261 | $4K | |
| 99222 | Initial hospital care, per day, moderate complexity | 99 | 96 | $4K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 31 | 30 | $3K |
| 93308 | 243 | 219 | $3K | |
| 93356 | 114 | 113 | $3K | |
| 99255 | 16 | 16 | $2K | |
| 94618 | 232 | 230 | $2K | |
| 93000 | 260 | 257 | $2K | |
| 43762 | 160 | 157 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 88 | 44 | $1K |
| 99223 | Prolong inpt eval add15 m | 47 | 41 | $1K |
| 94726 | 233 | 224 | $1K | |
| 96415 | 118 | 64 | $1K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 12 | 12 | $983.36 |
| J1756 | Injection, iron sucrose, 1 mg | 24 | 12 | $955.92 |
| 93325 | 406 | 390 | $794.41 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 43 | 27 | $707.07 |
| 99442 | 42 | 41 | $660.86 | |
| 95811 | 13 | 13 | $594.71 | |
| 93296 | 64 | 63 | $568.74 | |
| 93294 | 47 | 47 | $544.12 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 13 | 13 | $443.09 |
| 93321 | 136 | 126 | $367.09 | |
| 93297 | 77 | 69 | $343.29 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 61 | 51 | $331.29 |
| 93298 | 25 | 24 | $260.56 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 38 | 25 | $250.92 |
| 94060 | 28 | 28 | $177.32 | |
| 93320 | 12 | 12 | $154.38 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 103 | 65 | $146.00 |
| 99152 | 16 | 13 | $63.65 | |
| 99441 | 14 | 14 | $25.26 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 808 | 799 | $0.00 |